Bad news about rising COVID-19 cases is good news for these stocks.
News & Analysis: Co-Diagnostics, Inc.
This diagnostics company's stock is on fire in 2020 due to its coronavirus tests.
Another COVID-19 test maker's pain appears to be behind Co-Diagnostics stock's gain.
This coronavirus testing company's stock has increased 19 times in 2020.
The company announced two new markets for its COVID-19 diagnostics tests.
The company's COVID-19 test received a key validation.
Shares are taking a breather following a downgrade by an analyst at Maxim Group.
Investors liked the FDA's aggressive move to allow labs to use coronavirus tests, including one developed by Co-Diagnostics.
Shares of the medical diagnostics company keep churning higher.